[Comment] Focused ultrasound treatments could increase survival in individuals with glioma

The Lancet Oncology | |

Non-invasive and targeted transcranial focused ultrasound (FUS) treatments combined with systemically administered microbubbles enhance the delivered chemotherapeutic dose within brain tumours, due to reversible blood–brain barrier opening (BBBO).1–3 In preclinical studies, increased drug delivery has led to measurable overall survival benefit in animal models of high-grade glioma.4–7 However, to date, there has been no evidence of prolonged overall survival in…

Topics: blood-cancer, brain-cancer, chemotherapy, clinical-trials, new-technology